Status:
ACTIVE_NOT_RECRUITING
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Colorectal Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic ...
Detailed Description
PRIMARY OBJECTIVES: I. Test the efficacy of the HOPE-Genomics intervention in improving patient knowledge of genomics. II. Test the efficacy of the HOPE-Genomics intervention in improving patient re...
Eligibility Criteria
Inclusion
- Are enrolled in City of Hope (COH) Institutional Review Board (IRB) 07047
- Have a diagnosis of lung, breast, colorectal, pancreatic, ovarian or prostate cancer
- Having somatic, germline or paired somatic/germline sequencing
- Are fluent in English
- Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- Are \>= 18 years old
Exclusion
- Are unable to provide informed consent
Key Trial Info
Start Date :
December 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT04905082
Start Date
December 30 2021
End Date
December 31 2025
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010